1don MSN
Mayo Clinic researchers have found a new way to more precisely detect and monitor brain cell activity during deep brain ...
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.
Here's what to know about deep brain stimulation for Parkinson's disease. Doctors have offered deep brain stimulation to Parkinson’s patients since 2002. But until now, devices have only ...
Doctors have offered deep brain stimulation to Parkinson’s patients since 2002. But until now, devices have only provided continuous stimulation—not the dynamic and responsive activation that the ...
8don MSN
Though DBS will not cure the progression of the disease, it will improve the quality of life of advanced PD patients.
Parkinson's cases are set to double by 2050. Learn why it's rising and how lifestyle changes can support long-term brain ...
The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s disease. The new technology is expected to be available in the US later in 2025.
Bhubaneswar: In a groundbreaking achievement, the Institute of Medical Sciences and SUM Hospital has succesfully conducted ...
U.S. Deep Brain Stimulation In Parkinson’s Disease Market Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis ...
7don MSN
BHUBANESWAR: In a first in the state, the Institute of Medical Sciences and SUM Hospital has successfully conducted deep ...
11d
News-Medical.Net on MSNMedtronic receives FDA approval for BrainSense Adaptive DBS technologyFor the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results